192 related articles for article (PubMed ID: 880810)
21. Changes in coagulation and anticoagulation in women taking low-dose triphasic oral contraceptives: a controlled comparative 12-month clinical trial.
Notelovitz M; Kitchens CS; Khan FY
Am J Obstet Gynecol; 1992 Nov; 167(5):1255-61. PubMed ID: 1442974
[TBL] [Abstract][Full Text] [Related]
22. The effect of oral contraceptives on mononuclear cell cholesteryl ester hydrolase activity.
Hagemenas FC; Yatsu FM; Manaugh LC
Lipids; 1980 Jan; 15(1):39-44. PubMed ID: 7360009
[TBL] [Abstract][Full Text] [Related]
23. Effect of oral alanine loads on plasma amino acids in oral contraceptive users and control women.
Potera C; Rose DP
Am J Clin Nutr; 1978 May; 31(5):794-8. PubMed ID: 645627
[TBL] [Abstract][Full Text] [Related]
24. A quantitative study of the pregnancy zone protein in sera of woman taking oral contraceptives.
Damber MG; von Schoultz B; Solheim F; Stigbrand T
Am J Obstet Gynecol; 1976 Feb; 124(3):289-92. PubMed ID: 55075
[TBL] [Abstract][Full Text] [Related]
25. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
[TBL] [Abstract][Full Text] [Related]
26. Biochemical effects of treatment with oral contraceptive steroids on the dopaminergic system of the rat.
Algeri S; Ponzio F; Dolfini E; Jori A
Neuroendocrinology; 1976; 22(4):343-51. PubMed ID: 1030500
[TBL] [Abstract][Full Text] [Related]
27. The relative expressed estrogenicity of oral contraceptives.
Rooks WH; Kugler SL; Dorfman RI
Fertil Steril; 1968; 19(3):419-23. PubMed ID: 5647620
[TBL] [Abstract][Full Text] [Related]
28. Some aspects of studies with oral contraceptives in Indian women.
Shah PN
J Obstet Gynaecol India; 1966 Aug; 16(4):409-14. PubMed ID: 12262163
[TBL] [Abstract][Full Text] [Related]
29. Anti-estrogens and plasma proteins. II. Contraceptive drugs and gestagens.
Barbosa J; Seal US; Doe RP
J Clin Endocrinol Metab; 1973 Apr; 36(4):706-14. PubMed ID: 4119677
[TBL] [Abstract][Full Text] [Related]
30. Histopathological and histochemical changes in the cervix uteri under contraceptive pills.
El Hakim SM; Abdin FH; Kandil O
Egypt Popul Fam Plann Rev; 1976 Dec; 10(2):20-33. PubMed ID: 12308408
[TBL] [Abstract][Full Text] [Related]
31. Radioimmunoassay of unconjugated plasma ethynylestradiol in women given a single oral dose of ethynylestradiol or mestranol.
de la Pena A; Chenault CB; Goldzieher JW
Steroids; 1975 Jun; 25(6):773-80. PubMed ID: 1154455
[TBL] [Abstract][Full Text] [Related]
32. Carbohydrate metabolism during treatment with estrogen, progestogen, and low-dose oral contraceptives.
Spellacy WN
Am J Obstet Gynecol; 1982 Mar; 142(6 Pt 2):732-4. PubMed ID: 7039318
[TBL] [Abstract][Full Text] [Related]
33. Insulin sensitivity is decreased in normal women by doses of ethinyl estradiol used in oral contraceptives.
Kojima T; Lindheim SR; Duffy DM; Vijod MA; Stanczyk FZ; Lobo RA
Am J Obstet Gynecol; 1993 Dec; 169(6):1540-4. PubMed ID: 8267059
[TBL] [Abstract][Full Text] [Related]
34. Hormonal steroids: effects on the vascular system.
Solash J; Perez R; Keates JS; Ramasamy N; Stein H; Troyansky D; Ateyeh E; Jones JR; Srinivasan S; Sawyer PN
Gynecol Invest; 1975; 6(6):329-36. PubMed ID: 1213600
[TBL] [Abstract][Full Text] [Related]
35. Factors affecting pituitary gonadotropin function in users of oral contraceptive steroids.
Scott JA; Brenner PF; Kletzky OA; Mishell DR
Am J Obstet Gynecol; 1978 Apr; 130(7):817-21. PubMed ID: 345817
[TBL] [Abstract][Full Text] [Related]
36. Ovarian changes during and after long term steroid contraceptive therapy.
Hefnawi F; Sabry I; Kandil OF; Wassef SA; Younis N
Egypt Popul Fam Plann Rev; 1970 Jun; 3(1):67-76. PubMed ID: 12254510
[TBL] [Abstract][Full Text] [Related]
37. A comparison of Norinyl and Brevicon in three sites in Sri Lanka.
Basnayake S; de Silva SV; Miller PC; Rogers S
Contraception; 1983 May; 27(5):453-64. PubMed ID: 6884024
[TBL] [Abstract][Full Text] [Related]
38. Effect of oral contraceptives on plasma glucose, insulin, and glucagon levels.
Gossain VV; Sherma NK; Michelakis AM; Rovner DR
Am J Obstet Gynecol; 1983 Nov; 147(6):618-23. PubMed ID: 6356926
[TBL] [Abstract][Full Text] [Related]
39. Insulin resistance, secretion, and metabolism in users of oral contraceptives.
Godsland IF; Walton C; Felton C; Proudler A; Patel A; Wynn V
J Clin Endocrinol Metab; 1992 Jan; 74(1):64-70. PubMed ID: 1530790
[TBL] [Abstract][Full Text] [Related]
40. Endometrial changes induced by the administration of an oral contraceptive, norethindrone (S-3800B).
Utsumi K; Kuribayashi N; Kumakiri S
Acta Pathol Jpn; 1966 May; 16(2):141-50. PubMed ID: 6012525
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]